{"transactions":[{"id":696304,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":26395,"kind":"person","name":"Fischetti Gary P","position":1,"cik":"0001929510","reported_name":"Fischetti Gary P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-05T20:30:12.000Z","date":"2026-08-04","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":20.315,"value":20315.0,"ownership":{"direct":true},"balance_after":54015,"source":{"system":"sec-edgar","filing":"0001193125-26-335269","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526335269/ownership.xml","form_type":"4"}},{"id":696303,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":26395,"kind":"person","name":"Fischetti Gary P","position":1,"cik":"0001929510","reported_name":"Fischetti Gary P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-05T20:30:12.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":20.745,"value":20745.0,"ownership":{"direct":true},"balance_after":53015,"source":{"system":"sec-edgar","filing":"0001193125-26-335269","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526335269/ownership.xml","form_type":"4"}},{"id":729697,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":26395,"kind":"person","name":"Fischetti Gary P","position":1,"cik":"0001929510","reported_name":"Fischetti Gary P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T20:30:19.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":10402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2027 annual meeting of the Company's stockholders or June 18, 2027."}],"balance_after":52015,"source":{"system":"sec-edgar","filing":"0001193125-26-279545","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526279545/ownership.xml","form_type":"4"}},{"id":729696,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":36126,"kind":"person","name":"HENNEMAN JOHN B III","position":1,"cik":"0001187572","reported_name":"HENNEMAN JOHN B III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T20:30:14.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":10402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2027 annual meeting of the Company's stockholders or June 18, 2027."}],"balance_after":65273,"source":{"system":"sec-edgar","filing":"0001193125-26-279542","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526279542/ownership.xml","form_type":"4"}},{"id":729695,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":36125,"kind":"person","name":"Richard Stephen","position":1,"cik":"0001823843","reported_name":"Richard Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T20:30:13.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":10402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2027 annual meeting of the Company's stockholders or June 18, 2027."}],"balance_after":58273,"source":{"system":"sec-edgar","filing":"0001193125-26-279541","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526279541/ownership.xml","form_type":"4"}},{"id":729694,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":29747,"kind":"person","name":"Capper Joseph H","position":1,"cik":"0001456817","reported_name":"Capper Joseph H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T20:30:09.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":10402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2027 annual meeting of the Company's stockholders or June 18, 2027."}],"balance_after":30805,"source":{"system":"sec-edgar","filing":"0001193125-26-279539","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526279539/ownership.xml","form_type":"4"}},{"id":729693,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":36124,"kind":"person","name":"CONLEY SHERYL L","position":1,"cik":"0001238659","reported_name":"CONLEY SHERYL L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T20:30:03.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":10402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2027 annual meeting of the Company's stockholders or June 18, 2027."}],"balance_after":52970,"source":{"system":"sec-edgar","filing":"0001193125-26-279535","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526279535/ownership.xml","form_type":"4"}},{"id":748738,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":41114,"kind":"person","name":"Griffin Stephen D.","position":1,"cik":"0001831125","reported_name":"Griffin Stephen D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2026-06-05T20:05:07.000Z","date":"2026-06-03","kind":"exercise","planned":false,"acquired":false,"shares":12840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 3, 2024, the Reporting Person was granted 38,520 RSUs vesting in three equal annual installments beginning on June 3, 2025. This transaction reflects the second vesting installment of such RSU award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On June 3, 2024, the Reporting Person was granted 38,520 RSUs vesting in three equal annual installments beginning on June 3, 2025. This transaction reflects the second vesting installment of such RSU award."}],"balance_after":12840,"derivative":{"underlying":"Common Stock","underlying_shares":12840},"source":{"system":"sec-edgar","filing":"0001193125-26-259520","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526259520/ownership.xml","form_type":"4"}},{"id":748737,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":41114,"kind":"person","name":"Griffin Stephen D.","position":1,"cik":"0001831125","reported_name":"Griffin Stephen D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-06-05T20:05:07.000Z","date":"2026-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":3769,"price":14.41,"value":54311.29,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects an aggregate of 3,769 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on June 3, 2026."}],"balance_after":45973,"source":{"system":"sec-edgar","filing":"0001193125-26-259520","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526259520/ownership.xml","form_type":"4"}},{"id":748736,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":41114,"kind":"person","name":"Griffin Stephen D.","position":1,"cik":"0001831125","reported_name":"Griffin Stephen D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-06-05T20:05:07.000Z","date":"2026-06-03","kind":"exercise","planned":false,"acquired":true,"shares":12840,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 739 shares acquired on May 14, 2026 under the Anika Therapeutics, Inc. Employee Stock Purchase Plan."}],"balance_after":49742,"source":{"system":"sec-edgar","filing":"0001193125-26-259520","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526259520/ownership.xml","form_type":"4"}},{"id":794511,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":36126,"kind":"person","name":"HENNEMAN JOHN B III","position":1,"cik":"0001187572","reported_name":"HENNEMAN JOHN B III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T12:34:30.000Z","date":"2026-05-01","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":14.6639,"value":73319.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $14.595 to $14.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":54871,"source":{"system":"sec-edgar","filing":"0001193125-26-202704","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526202704/ownership.xml","form_type":"4"}},{"id":797385,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":41114,"kind":"person","name":"Griffin Stephen D.","position":1,"cik":"0001831125","reported_name":"Griffin Stephen D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-04-30T21:22:40.000Z","date":"2026-04-30","kind":"purchase","planned":false,"acquired":true,"shares":12200,"price":12.2853,"value":149880.66,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.235 to $12.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":36163,"source":{"system":"sec-edgar","filing":"0001193125-26-197887","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526197887/ownership.xml","form_type":"4"}},{"id":831516,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Premium Priced Stock Appreciation Rights","published_at":"2026-03-23T21:23:05.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":17663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents a Premium Priced Stock Appreciation Right (\"PPSAR\") granted under the 2017 Plan. The PPSAR exercise price per share is equal to 110% of the Fair Market Value (as defined in the 2017 Plan) of a share of common stock on the Grant Date. The PPSAR vests in three equal annual installments beginning March 19, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date. The PPSAR is payable in cash, shares of common stock, or a combination thereof, at the Issuer's discretion, in accordance with the 2017 Plan, as amended, and the applicable award agreement."}],"balance_after":17663,"derivative":{"exercise_price":15.6,"expiration_date":"2036-03-19","underlying":"Common Stock","underlying_shares":17663},"source":{"system":"sec-edgar","filing":"0001193125-26-120005","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526120005/ownership.xml","form_type":"4"}},{"id":831515,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2026-03-23T21:23:05.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":11194,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the contingent right to receive, at the Issuer's discretion, one share of the Issuer's common stock, or the cash equivalent of the closing price of one share of the Issuer's common stock, on each vest date, in accordance with the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan, as amended (the \"2017 Plan\"), and the applicable award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests fully on March 19, 2029, subject to the Reporting Person's continuous service to the Issuer as of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Vests fully on March 19, 2029, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":11194,"derivative":{"underlying":"Common Stock","underlying_shares":11194},"source":{"system":"sec-edgar","filing":"0001193125-26-120005","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526120005/ownership.xml","form_type":"4"}},{"id":831514,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2026-03-23T21:23:05.000Z","date":"2026-03-19","kind":"grant","planned":false,"acquired":true,"shares":13097,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the contingent right to receive, at the Issuer's discretion, one share of the Issuer's common stock, or the cash equivalent of the closing price of one share of the Issuer's common stock, on each vest date, in accordance with the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan, as amended (the \"2017 Plan\"), and the applicable award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in three equal annual installments, with the first installment vesting on March 19, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Vests in three equal annual installments, with the first installment vesting on March 19, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":13097,"derivative":{"underlying":"Common Stock","underlying_shares":13097},"source":{"system":"sec-edgar","filing":"0001193125-26-120005","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526120005/ownership.xml","form_type":"4"}},{"id":839788,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2026-03-17T23:47:22.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":6449,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 15, 2024, the Reporting Person was granted 19,345 RSUs vesting in three equal annual installments beginning on March 15, 2025. This transaction reflects the second vesting installment of such RSU award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 15, 2024, the Reporting Person was granted 19,345 RSUs vesting in three equal annual installments beginning on March 15, 2025. This transaction reflects the second vesting installment of such RSU award."}],"balance_after":6448,"derivative":{"underlying":"Common Stock","underlying_shares":6449},"source":{"system":"sec-edgar","filing":"0001193125-26-111511","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111511/ownership.xml","form_type":"4"}},{"id":839787,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2026-03-17T23:47:22.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":false,"shares":9388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 14, 2025, the Reporting Person was granted 28,165 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On March 14, 2025, the Reporting Person was granted 28,165 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award."}],"balance_after":18777,"derivative":{"underlying":"Common Stock","underlying_shares":9388},"source":{"system":"sec-edgar","filing":"0001193125-26-111511","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111511/ownership.xml","form_type":"4"}},{"id":839786,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2026-03-17T23:47:22.000Z","date":"2026-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1893,"price":14.2,"value":26880.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Reflects an aggregate of  1,893 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 15, 2026."}],"balance_after":67570,"source":{"system":"sec-edgar","filing":"0001193125-26-111511","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111511/ownership.xml","form_type":"4"}},{"id":839785,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2026-03-17T23:47:22.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":6449,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."}],"balance_after":69463,"source":{"system":"sec-edgar","filing":"0001193125-26-111511","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111511/ownership.xml","form_type":"4"}},{"id":839784,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2026-03-17T23:47:22.000Z","date":"2026-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":4168,"price":14.2,"value":59185.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects an aggregate of 4,694 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs and PSUs that vested on March 14, 2026."}],"balance_after":63014,"source":{"system":"sec-edgar","filing":"0001193125-26-111511","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111511/ownership.xml","form_type":"4"}},{"id":839783,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2026-03-17T23:47:22.000Z","date":"2026-03-14","kind":"grant","planned":false,"acquired":true,"shares":4694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On March 14, 2025, the Reporting Person was granted 14,082 performance-based phantom RSUs (\"PSUs\") with vesting contingent upon the achievement of pre-established performance and strategic targets. This transaction represents the first vesting installment of such PSU award."}],"balance_after":67182,"source":{"system":"sec-edgar","filing":"0001193125-26-111511","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111511/ownership.xml","form_type":"4"}},{"id":839782,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2026-03-17T23:47:22.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":true,"shares":9388,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."}],"balance_after":62488,"source":{"system":"sec-edgar","filing":"0001193125-26-111511","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111511/ownership.xml","form_type":"4"}},{"id":839781,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":41114,"kind":"person","name":"Griffin Stephen D.","position":1,"cik":"0001831125","reported_name":"Griffin Stephen D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2026-03-17T23:44:08.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":false,"shares":12824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 14, 2025, the Reporting Person was granted 38,473 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 14, 2025, the Reporting Person was granted 38,473 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award."}],"balance_after":25649,"derivative":{"underlying":"Common Stock","underlying_shares":12824},"source":{"system":"sec-edgar","filing":"0001193125-26-111502","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111502/ownership.xml","form_type":"4"}},{"id":839780,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":41114,"kind":"person","name":"Griffin Stephen D.","position":1,"cik":"0001831125","reported_name":"Griffin Stephen D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-17T23:44:08.000Z","date":"2026-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":5944,"price":14.2,"value":84404.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects an aggregate of 5,944 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs and PSUs that vested on March 14, 2026."}],"balance_after":23963,"source":{"system":"sec-edgar","filing":"0001193125-26-111502","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111502/ownership.xml","form_type":"4"}},{"id":839779,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":41114,"kind":"person","name":"Griffin Stephen D.","position":1,"cik":"0001831125","reported_name":"Griffin Stephen D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-17T23:44:08.000Z","date":"2026-03-14","kind":"grant","planned":false,"acquired":true,"shares":6412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On March 14, 2025, the Reporting Person was granted 19,236 performance-based phantom RSUs (\"PSUs\") with vesting contingent upon the achievement of pre-established performance and strategic targets. This transaction represents the first vesting installment of such PSU award."}],"balance_after":29907,"source":{"system":"sec-edgar","filing":"0001193125-26-111502","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111502/ownership.xml","form_type":"4"}},{"id":839778,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":41114,"kind":"person","name":"Griffin Stephen D.","position":1,"cik":"0001831125","reported_name":"Griffin Stephen D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-17T23:44:08.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":true,"shares":12824,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."}],"balance_after":23495,"source":{"system":"sec-edgar","filing":"0001193125-26-111502","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111502/ownership.xml","form_type":"4"}},{"id":839777,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-03-17T23:42:01.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":25131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On March 15, 2024, the Reporting Person was granted 75,395 RSUs vesting in three equal annual installments beginning on March 15, 2025. This transaction reflects the second vesting installment of such RSU award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On March 15, 2024, the Reporting Person was granted 75,395 RSUs vesting in three equal annual installments beginning on March 15, 2025. This transaction reflects the second vesting installment of such RSU award."}],"balance_after":25132,"derivative":{"underlying":"Common Stock","underlying_shares":25131},"source":{"system":"sec-edgar","filing":"0001193125-26-111494","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111494/ownership.xml","form_type":"4"}},{"id":839776,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-03-17T23:42:01.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":false,"shares":24519,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 14, 2025, the Reporting Person was granted 73,559 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 14, 2025, the Reporting Person was granted 73,559 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award."}],"balance_after":49040,"derivative":{"underlying":"Common Stock","underlying_shares":24519},"source":{"system":"sec-edgar","filing":"0001193125-26-111494","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111494/ownership.xml","form_type":"4"}},{"id":839775,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-17T23:42:01.000Z","date":"2026-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":12104,"price":14.2,"value":171876.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Reflects an aggregate of 12,104 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 15, 2026."}],"balance_after":258788,"source":{"system":"sec-edgar","filing":"0001193125-26-111494","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111494/ownership.xml","form_type":"4"}},{"id":839774,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-17T23:42:01.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":25131,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."}],"balance_after":270892,"source":{"system":"sec-edgar","filing":"0001193125-26-111494","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111494/ownership.xml","form_type":"4"}},{"id":839773,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-17T23:42:01.000Z","date":"2026-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":14728,"price":14.2,"value":209137.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects an aggregate of 14,728 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs and PSUs that vested on March 14, 2026."}],"balance_after":245761,"source":{"system":"sec-edgar","filing":"0001193125-26-111494","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111494/ownership.xml","form_type":"4"}},{"id":839772,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-17T23:42:01.000Z","date":"2026-03-14","kind":"grant","planned":false,"acquired":true,"shares":24520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On March 14, 2025, the Reporting Person was granted 73,559 performance-based phantom RSUs (\"PSUs\") with vesting contingent upon the achievement of pre-established performance and strategic targets. This transaction represents the first vesting installment of such PSU award."}],"balance_after":260489,"source":{"system":"sec-edgar","filing":"0001193125-26-111494","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111494/ownership.xml","form_type":"4"}},{"id":839771,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-17T23:42:01.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":true,"shares":24519,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."}],"balance_after":235969,"source":{"system":"sec-edgar","filing":"0001193125-26-111494","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111494/ownership.xml","form_type":"4"}},{"id":839767,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2026-03-17T23:39:47.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":2658,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 15, 2024, the Reporting Person was granted 7,976 RSUs vesting in three equal annual installments beginning on March 15, 2025. This transaction reflects the second vesting installment of such RSU award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 15, 2024, the Reporting Person was granted 7,976 RSUs vesting in three equal annual installments beginning on March 15, 2025. This transaction reflects the second vesting installment of such RSU award."}],"balance_after":2659,"derivative":{"underlying":"Common Stock","underlying_shares":2658},"source":{"system":"sec-edgar","filing":"0001193125-26-111492","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111492/ownership.xml","form_type":"4"}},{"id":839766,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2026-03-17T23:39:47.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":false,"shares":3774,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 14, 2025, the Reporting Person was granted 11,324 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On March 14, 2025, the Reporting Person was granted 11,324 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award."}],"balance_after":7550,"derivative":{"underlying":"Common Stock","underlying_shares":3774},"source":{"system":"sec-edgar","filing":"0001193125-26-111492","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111492/ownership.xml","form_type":"4"}},{"id":839765,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Common Stock","published_at":"2026-03-17T23:39:47.000Z","date":"2026-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":781,"price":14.2,"value":11090.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Reflects an aggregate of 781 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 15, 2026."}],"balance_after":24107,"source":{"system":"sec-edgar","filing":"0001193125-26-111492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111492/ownership.xml","form_type":"4"}},{"id":839764,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Common Stock","published_at":"2026-03-17T23:39:47.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":2658,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."}],"balance_after":24888,"source":{"system":"sec-edgar","filing":"0001193125-26-111492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111492/ownership.xml","form_type":"4"}},{"id":839763,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Common Stock","published_at":"2026-03-17T23:39:47.000Z","date":"2026-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1449,"price":14.2,"value":20575.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects an aggregate of 1,449 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs and PSUs that vested on March 14, 2026."}],"balance_after":22230,"source":{"system":"sec-edgar","filing":"0001193125-26-111492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111492/ownership.xml","form_type":"4"}},{"id":839762,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Common Stock","published_at":"2026-03-17T23:39:47.000Z","date":"2026-03-14","kind":"grant","planned":false,"acquired":true,"shares":1161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On March 14, 2025, the Reporting Person was granted 3,484 performance-based phantom RSUs (\"PSUs\") with vesting contingent upon the achievement of pre-established performance and strategic targets. This transaction represents the first vesting installment of such PSU award."}],"balance_after":23679,"source":{"system":"sec-edgar","filing":"0001193125-26-111492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111492/ownership.xml","form_type":"4"}},{"id":839761,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Common Stock","published_at":"2026-03-17T23:39:47.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":true,"shares":3774,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."}],"balance_after":22518,"source":{"system":"sec-edgar","filing":"0001193125-26-111492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526111492/ownership.xml","form_type":"4"}},{"id":849586,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2026-03-11T20:25:11.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":false,"shares":5465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 9, 2023, the Reporting Person was granted 16,395 RSUs vesting in three equal annual installments beginning on March 9, 2024. This transaction reflects the third and final vesting installment of such RSU award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 9, 2023, the Reporting Person was granted 16,395 RSUs vesting in three equal annual installments beginning on March 9, 2024. This transaction reflects the third and final vesting installment of such RSU award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5465},"source":{"system":"sec-edgar","filing":"0001193125-26-102240","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526102240/ownership.xml","form_type":"4"}},{"id":849585,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2026-03-11T20:25:11.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":1919,"price":14.96,"value":28708.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects an aggregate of 1,919 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2026."}],"balance_after":53100,"source":{"system":"sec-edgar","filing":"0001193125-26-102240","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526102240/ownership.xml","form_type":"4"}},{"id":849584,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2026-03-11T20:25:11.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":true,"shares":5465,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 800 shares purchased on May 14, 2025 and 800 shares purchased on November 14, 2025."}],"balance_after":55019,"source":{"system":"sec-edgar","filing":"0001193125-26-102240","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526102240/ownership.xml","form_type":"4"}},{"id":849589,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-03-11T20:24:57.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":false,"shares":20001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 9, 2023, the Reporting Person was granted 60,004 RSUs vesting in three equal annual installments beginning on March 9, 2024. This transaction reflects the third and final vesting installment of such RSU award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 9, 2023, the Reporting Person was granted 60,004 RSUs vesting in three equal annual installments beginning on March 9, 2024. This transaction reflects the third and final vesting installment of such RSU award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20001},"source":{"system":"sec-edgar","filing":"0001193125-26-102239","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526102239/ownership.xml","form_type":"4"}},{"id":849588,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-11T20:24:57.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":5871,"price":14.96,"value":87830.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an aggregate of 5,871 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2026."}],"balance_after":211450,"source":{"system":"sec-edgar","filing":"0001193125-26-102239","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526102239/ownership.xml","form_type":"4"}},{"id":849587,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-11T20:24:57.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":true,"shares":20001,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."}],"balance_after":217321,"source":{"system":"sec-edgar","filing":"0001193125-26-102239","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526102239/ownership.xml","form_type":"4"}},{"id":849582,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2026-03-11T20:24:43.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":false,"shares":2197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 9, 2023, the Reporting Person was granted 6,590 RSUs vesting in three equal annual installments beginning on March 9, 2024. This transaction reflects the third and final vesting installment of such RSU award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 9, 2023, the Reporting Person was granted 6,590 RSUs vesting in three equal annual installments beginning on March 9, 2024. This transaction reflects the third and final vesting installment of such RSU award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2197},"source":{"system":"sec-edgar","filing":"0001193125-26-102238","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526102238/ownership.xml","form_type":"4"}},{"id":849581,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Common Stock","published_at":"2026-03-11T20:24:43.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":639,"price":14.96,"value":9559.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects an aggregate of 639 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2026."}],"balance_after":18744,"source":{"system":"sec-edgar","filing":"0001193125-26-102238","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526102238/ownership.xml","form_type":"4"}},{"id":849580,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":56686,"kind":"person","name":"McLeod Ian","position":1,"cik":"0001447910","reported_name":"McLeod Ian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CAO & Treasurer"}}],"security":"Common Stock","published_at":"2026-03-11T20:24:43.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":true,"shares":2197,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of Issuer common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 528 shares purchased on May 14, 2025 and 616 shares purchased on November 14, 2025."}],"balance_after":19383,"source":{"system":"sec-edgar","filing":"0001193125-26-102238","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526102238/ownership.xml","form_type":"4"}},{"id":922977,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":41114,"kind":"person","name":"Griffin Stephen D.","position":1,"cik":"0001831125","reported_name":"Griffin Stephen D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-03T23:45:54.000Z","date":"2026-02-01","kind":"grant","planned":false,"acquired":true,"shares":130402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents the contingent right to receive, at the Issuer's discretion, one share of the Issuer's common stock, or the cash equivalent of the closing price of one share of the Issuer's common stock, on each vest date, in accordance with the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan, as amended, and the applicable award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests in three equal annual installments, with the first installment vesting on February 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Vests in three equal annual installments, with the first installment vesting on February 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":130402,"derivative":{"underlying":"Common Stock","underlying_shares":130402},"source":{"system":"sec-edgar","filing":"0001193125-26-036129","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526036129/ownership.xml","form_type":"4"}},{"id":922976,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":41114,"kind":"person","name":"Griffin Stephen D.","position":1,"cik":"0001831125","reported_name":"Griffin Stephen D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Appreciation Rights","published_at":"2026-02-03T23:45:54.000Z","date":"2026-02-01","kind":"grant","planned":false,"acquired":true,"shares":310207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Stock Appreciation Right is payable in cash, shares of common stock, or a combination thereof, in accordance with the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan, as amended, and the applicable award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests in three equal annual installments, with the first installment vesting on February 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":310207,"derivative":{"exercise_price":9.23,"expiration_date":"2036-02-01","underlying":"Common Stock","underlying_shares":310207},"source":{"system":"sec-edgar","filing":"0001193125-26-036129","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000119312526036129/ownership.xml","form_type":"4"}},{"id":1103245,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":78211,"kind":"person","name":"VOGT SUSAN L N","position":1,"cik":"0001191270","reported_name":"VOGT SUSAN L N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T21:14:37.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":14164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2026 annual meeting of the Company's stockholders or June 20, 2026."}],"balance_after":50213,"source":{"system":"sec-edgar","filing":"0001171843-25-004072","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325004072/ownership.xml","form_type":"4"}},{"id":1103246,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":36125,"kind":"person","name":"Richard Stephen","position":1,"cik":"0001823843","reported_name":"Richard Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T21:13:40.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":14164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2026 annual meeting of the Company's stockholders or June 20, 2026."}],"balance_after":47871,"source":{"system":"sec-edgar","filing":"0001171843-25-004071","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325004071/ownership.xml","form_type":"4"}},{"id":1103244,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":78210,"kind":"person","name":"Larsen Glenn R.","position":1,"cik":"0001633737","reported_name":"Larsen Glenn R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T21:13:04.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":14164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2026 annual meeting of the Company's stockholders or June 20, 2026."}],"balance_after":50258,"source":{"system":"sec-edgar","filing":"0001171843-25-004070","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325004070/ownership.xml","form_type":"4"}},{"id":1103243,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":16455,"kind":"person","name":"Jellison William R","position":1,"cik":"0001189883","reported_name":"Jellison William R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T21:12:27.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":14164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2026 annual meeting of the Company's stockholders or June 20, 2026."}],"balance_after":20403,"source":{"system":"sec-edgar","filing":"0001171843-25-004069","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325004069/ownership.xml","form_type":"4"}},{"id":1103242,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":36126,"kind":"person","name":"HENNEMAN JOHN B III","position":1,"cik":"0001187572","reported_name":"HENNEMAN JOHN B III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T21:06:28.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":14164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2026 annual meeting of the Company's stockholders or June 20, 2026."}],"balance_after":49871,"source":{"system":"sec-edgar","filing":"0001171843-25-004067","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325004067/ownership.xml","form_type":"4"}},{"id":1103241,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":26395,"kind":"person","name":"Fischetti Gary P","position":1,"cik":"0001929510","reported_name":"Fischetti Gary P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T21:06:05.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":14164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2026 annual meeting of the Company's stockholders or June 20, 2026."}],"balance_after":41613,"source":{"system":"sec-edgar","filing":"0001171843-25-004065","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325004065/ownership.xml","form_type":"4"}},{"id":1103240,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":36124,"kind":"person","name":"CONLEY SHERYL L","position":1,"cik":"0001238659","reported_name":"CONLEY SHERYL L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T21:05:30.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":14164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2026 annual meeting of the Company's stockholders or June 20, 2026."}],"balance_after":42568,"source":{"system":"sec-edgar","filing":"0001171843-25-004064","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325004064/ownership.xml","form_type":"4"}},{"id":1103239,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":29747,"kind":"person","name":"Capper Joseph H","position":1,"cik":"0001456817","reported_name":"Capper Joseph H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T21:04:54.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":14164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2026 annual meeting of the Company's stockholders or June 20, 2026."}],"balance_after":20403,"source":{"system":"sec-edgar","filing":"0001171843-25-004063","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325004063/ownership.xml","form_type":"4"}},{"id":1122032,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":41114,"kind":"person","name":"Griffin Stephen D.","position":1,"cik":"0001831125","reported_name":"Griffin Stephen D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & COO"}}],"security":"Restricted Stock Unit","published_at":"2025-06-05T21:01:13.000Z","date":"2025-06-03","kind":"exercise","planned":false,"acquired":true,"shares":12840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning June 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning June 3, 2025."}],"balance_after":25680,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12840},"source":{"system":"sec-edgar","filing":"0001171843-25-003729","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325003729/ownership.xml","form_type":"4"}},{"id":1122031,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":41114,"kind":"person","name":"Griffin Stephen D.","position":1,"cik":"0001831125","reported_name":"Griffin Stephen D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & COO"}}],"security":"Common Stock","published_at":"2025-06-05T21:01:13.000Z","date":"2025-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":3769,"price":11.59,"value":43682.71,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects an aggregate of 3,769 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the closing price of ANIK common stock on June 3, 2025, the trading date on which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":9871,"source":{"system":"sec-edgar","filing":"0001171843-25-003729","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325003729/ownership.xml","form_type":"4"}},{"id":1122030,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":41114,"kind":"person","name":"Griffin Stephen D.","position":1,"cik":"0001831125","reported_name":"Griffin Stephen D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & COO"}}],"security":"Common Stock","published_at":"2025-06-05T21:01:13.000Z","date":"2025-06-03","kind":"exercise","planned":false,"acquired":true,"shares":12840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the first vesting installment of RSUs granted on June 3, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 800 shares acquired on May 14, 2025 under the Anika Therapeutics, Inc. Employee Stock Purchase Plan."}],"balance_after":13640,"source":{"system":"sec-edgar","filing":"0001171843-25-003729","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325003729/ownership.xml","form_type":"4"}},{"id":1201996,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-03-18T21:16:55.000Z","date":"2025-03-17","kind":"exercise","planned":false,"acquired":false,"shares":3637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 15, 2025."}],"balance_after":7275,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3637},"source":{"system":"sec-edgar","filing":"0001171843-25-001534","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001534/ownership.xml","form_type":"4"}},{"id":1201995,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-03-18T21:16:55.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":4650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on the vest date. The 4,650 RSUs represent the Target number of shares that may be earned in conjunction with certain market metrics prescribed under the terms of the performance-based phantom RSU award. The award shall cliff vest on the 3rd anniversary of the grant date, subject to the Compensation Committee's determination of achievement of the award prior to the vest date. The number of shares earned and subject to vest, as determined by the Compensation Committee, may be in a range from Threshold (50% of Target) to Maximum (200% of Target). No shares shall vest for achievement under Threshold."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on the vest date. The 4,650 RSUs represent the Target number of shares that may be earned in conjunction with certain market metrics prescribed under the terms of the performance-based phantom RSU award. The award shall cliff vest on the 3rd anniversary of the grant date, subject to the Compensation Committee's determination of achievement of the award prior to the vest date. The number of shares earned and subject to vest, as determined by the Compensation Committee, may be in a range from Threshold (50% of Target) to Maximum (200% of Target). No shares shall vest for achievement under Threshold."}],"balance_after":4650,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4650},"source":{"system":"sec-edgar","filing":"0001171843-25-001534","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001534/ownership.xml","form_type":"4"}},{"id":1201994,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-03-18T21:16:55.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":20761,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 14, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 14, 2026."}],"balance_after":20761,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":20761},"source":{"system":"sec-edgar","filing":"0001171843-25-001534","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001534/ownership.xml","form_type":"4"}},{"id":1201993,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Common Stock","published_at":"2025-03-18T21:16:55.000Z","date":"2025-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":1068,"price":15.91,"value":16991.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an aggregate of 1,068 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the closing price of ANIK common stock on March 14, 2025, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":20654,"source":{"system":"sec-edgar","filing":"0001171843-25-001534","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001534/ownership.xml","form_type":"4"}},{"id":1201992,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Common Stock","published_at":"2025-03-18T21:16:55.000Z","date":"2025-03-17","kind":"exercise","planned":false,"acquired":true,"shares":3637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the first vesting installment of RSUs granted on March 15, 2024, which the Company elected to settle in shares."}],"balance_after":21722,"source":{"system":"sec-edgar","filing":"0001171843-25-001534","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001534/ownership.xml","form_type":"4"}},{"id":1201991,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":41114,"kind":"person","name":"Griffin Stephen D.","position":1,"cik":"0001831125","reported_name":"Griffin Stephen D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2025-03-18T21:16:34.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":18672,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on the vest date. The 18,672 RSUs represent the Target number of shares that may be earned in conjunction with certain market metrics prescribed under the terms of the performance-based phantom RSU award. The award shall cliff vest on the 3rd anniversary of the grant date, subject to the Compensation Committee's determination of achievement of the award prior to the vest date. The number of shares earned and subject to vest, as determined by the Compensation Committee, may be in a range from Threshold (50% of Target) to Maximum (200% of Target). No shares shall vest for achievement under Threshold."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on the vest date. The 18,672 RSUs represent the Target number of shares that may be earned in conjunction with certain market metrics prescribed under the terms of the performance-based phantom RSU award. The award shall cliff vest on the 3rd anniversary of the grant date, subject to the Compensation Committee's determination of achievement of the award prior to the vest date. The number of shares earned and subject to vest, as determined by the Compensation Committee, may be in a range from Threshold (50% of Target) to Maximum (200% of Target). No shares shall vest for achievement under Threshold."}],"balance_after":18672,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":18672},"source":{"system":"sec-edgar","filing":"0001171843-25-001533","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001533/ownership.xml","form_type":"4"}},{"id":1201990,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":41114,"kind":"person","name":"Griffin Stephen D.","position":1,"cik":"0001831125","reported_name":"Griffin Stephen D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2025-03-18T21:16:34.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":38473,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 14, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 14, 2026."}],"balance_after":38473,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":38473},"source":{"system":"sec-edgar","filing":"0001171843-25-001533","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001533/ownership.xml","form_type":"4"}},{"id":1201989,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2025-03-18T21:16:12.000Z","date":"2025-03-17","kind":"exercise","planned":false,"acquired":false,"shares":6448,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 15, 2025."}],"balance_after":12897,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6448},"source":{"system":"sec-edgar","filing":"0001171843-25-001532","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001532/ownership.xml","form_type":"4"}},{"id":1201988,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2025-03-18T21:16:12.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":13669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on the vest date. The 13,669 RSUs represent the Target number of shares that may be earned in conjunction with certain market metrics prescribed under the terms of the performance-based phantom RSU award. The award shall cliff vest on the 3rd anniversary of the grant date, subject to the Compensation Committee's determination of achievement of the award prior to the vest date. The number of shares earned and subject to vest, as determined by the Compensation Committee, may be in a range from Threshold (50% of Target) to Maximum (200% of Target). No shares shall vest for achievement under Threshold."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on the vest date. The 13,669 RSUs represent the Target number of shares that may be earned in conjunction with certain market metrics prescribed under the terms of the performance-based phantom RSU award. The award shall cliff vest on the 3rd anniversary of the grant date, subject to the Compensation Committee's determination of achievement of the award prior to the vest date. The number of shares earned and subject to vest, as determined by the Compensation Committee, may be in a range from Threshold (50% of Target) to Maximum (200% of Target). No shares shall vest for achievement under Threshold."}],"balance_after":13669,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13669},"source":{"system":"sec-edgar","filing":"0001171843-25-001532","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001532/ownership.xml","form_type":"4"}},{"id":1201987,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2025-03-18T21:16:12.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":28165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 14, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 14, 2026."}],"balance_after":28165,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":28165},"source":{"system":"sec-edgar","filing":"0001171843-25-001532","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001532/ownership.xml","form_type":"4"}},{"id":1201986,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2025-03-18T21:16:12.000Z","date":"2025-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":1893,"price":15.91,"value":30117.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an aggregate of 1,893 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the closing price of ANIK common stock on March 14, 2025, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":47954,"source":{"system":"sec-edgar","filing":"0001171843-25-001532","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001532/ownership.xml","form_type":"4"}},{"id":1201985,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2025-03-18T21:16:12.000Z","date":"2025-03-17","kind":"exercise","planned":false,"acquired":true,"shares":6448,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the first vesting installment of RSUs granted on March 15, 2024, which the Company elected to settle in shares."}],"balance_after":49847,"source":{"system":"sec-edgar","filing":"0001171843-25-001532","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001532/ownership.xml","form_type":"4"}},{"id":1201984,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, Director"}}],"security":"Restricted Stock Unit","published_at":"2025-03-18T21:15:49.000Z","date":"2025-03-17","kind":"exercise","planned":false,"acquired":false,"shares":25132,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 15, 2025."}],"balance_after":50263,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":25132},"source":{"system":"sec-edgar","filing":"0001171843-25-001531","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001531/ownership.xml","form_type":"4"}},{"id":1201983,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, Director"}}],"security":"Restricted Stock Unit","published_at":"2025-03-18T21:15:49.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":71403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on the vest date. The 71,403 RSUs represent the Target number of shares that may be earned in conjunction with certain market metrics prescribed under the terms of the performance-based phantom RSU award. The award shall cliff vest on the 3rd anniversary of the grant date, subject to the Compensation Committee's determination of achievement of the award prior to the vest date. The number of shares earned and subject to vest, as determined by the Compensation Committee, may be in a range from Threshold (50% of Target) to Maximum (200% of Target). No shares shall vest for achievement under Threshold."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on the vest date. The 71,403 RSUs represent the Target number of shares that may be earned in conjunction with certain market metrics prescribed under the terms of the performance-based phantom RSU award. The award shall cliff vest on the 3rd anniversary of the grant date, subject to the Compensation Committee's determination of achievement of the award prior to the vest date. The number of shares earned and subject to vest, as determined by the Compensation Committee, may be in a range from Threshold (50% of Target) to Maximum (200% of Target). No shares shall vest for achievement under Threshold."}],"balance_after":71403,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":71403},"source":{"system":"sec-edgar","filing":"0001171843-25-001531","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001531/ownership.xml","form_type":"4"}},{"id":1201982,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, Director"}}],"security":"Restricted Stock Unit","published_at":"2025-03-18T21:15:49.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":73559,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 14, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 14, 2026."}],"balance_after":73559,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":73559},"source":{"system":"sec-edgar","filing":"0001171843-25-001531","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001531/ownership.xml","form_type":"4"}},{"id":1201981,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, Director"}}],"security":"Common Stock","published_at":"2025-03-18T21:15:49.000Z","date":"2025-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":12152,"price":15.91,"value":193338.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an aggregate of 12,152 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the closing price of ANIK common stock on March 14, 2025, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":197320,"source":{"system":"sec-edgar","filing":"0001171843-25-001531","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001531/ownership.xml","form_type":"4"}},{"id":1201980,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, Director"}}],"security":"Common Stock","published_at":"2025-03-18T21:15:49.000Z","date":"2025-03-17","kind":"exercise","planned":false,"acquired":true,"shares":25132,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the first vesting installment of phantom RSUs granted on March 15, 2024, which the Company elected to settle in shares."}],"balance_after":209472,"source":{"system":"sec-edgar","filing":"0001171843-25-001531","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001531/ownership.xml","form_type":"4"}},{"id":1208414,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-03-13T21:19:35.000Z","date":"2025-03-11","kind":"exercise","planned":false,"acquired":false,"shares":2561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2561},"source":{"system":"sec-edgar","filing":"0001171843-25-001470","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001470/ownership.xml","form_type":"4"}},{"id":1208413,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Common Stock","published_at":"2025-03-13T21:19:35.000Z","date":"2025-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":752,"price":16.79,"value":12626.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an aggregate of 752 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the closing price of ANIK common stock on March 11, 2025, the trading day to which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":18085,"source":{"system":"sec-edgar","filing":"0001171843-25-001470","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001470/ownership.xml","form_type":"4"}},{"id":1208412,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Common Stock","published_at":"2025-03-13T21:19:35.000Z","date":"2025-03-11","kind":"exercise","planned":false,"acquired":true,"shares":2561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the third and final vesting installment of RSUs granted on March 11, 2022."}],"balance_after":18837,"source":{"system":"sec-edgar","filing":"0001171843-25-001470","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001470/ownership.xml","form_type":"4"}},{"id":1208411,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2025-03-13T21:18:40.000Z","date":"2025-03-11","kind":"exercise","planned":false,"acquired":false,"shares":7663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":7663},"source":{"system":"sec-edgar","filing":"0001171843-25-001468","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001468/ownership.xml","form_type":"4"}},{"id":1208410,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2025-03-13T21:18:40.000Z","date":"2025-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":2250,"price":16.79,"value":37777.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an aggregate of 2,250 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the closing price of ANIK common stock on March 11, 2025, the trading day to which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":43399,"source":{"system":"sec-edgar","filing":"0001171843-25-001468","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001468/ownership.xml","form_type":"4"}},{"id":1208409,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2025-03-13T21:18:40.000Z","date":"2025-03-11","kind":"exercise","planned":false,"acquired":true,"shares":7663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the third and final vesting installment of RSUs granted on March 11, 2022."}],"balance_after":45649,"source":{"system":"sec-edgar","filing":"0001171843-25-001468","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001468/ownership.xml","form_type":"4"}},{"id":1208408,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, Director"}}],"security":"Restricted Stock Unit","published_at":"2025-03-13T21:15:43.000Z","date":"2025-03-11","kind":"exercise","planned":false,"acquired":false,"shares":30060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":30060},"source":{"system":"sec-edgar","filing":"0001171843-25-001467","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001467/ownership.xml","form_type":"4"}},{"id":1208407,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, Director"}}],"security":"Common Stock","published_at":"2025-03-13T21:15:43.000Z","date":"2025-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":12675,"price":16.79,"value":212813.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an aggregate of 12,675 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the closing price of ANIK common stock on March 11, 2025, the trading day to which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":184340,"source":{"system":"sec-edgar","filing":"0001171843-25-001467","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001467/ownership.xml","form_type":"4"}},{"id":1208406,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, Director"}}],"security":"Common Stock","published_at":"2025-03-13T21:15:43.000Z","date":"2025-03-11","kind":"exercise","planned":false,"acquired":true,"shares":30060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the third and final vesting installment of RSUs granted on March 11, 2022."}],"balance_after":197015,"source":{"system":"sec-edgar","filing":"0001171843-25-001467","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001467/ownership.xml","form_type":"4"}},{"id":1213503,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-03-11T21:18:31.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":3296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024."}],"balance_after":3295,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3296},"source":{"system":"sec-edgar","filing":"0001171843-25-001406","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001406/ownership.xml","form_type":"4"}},{"id":1213502,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Common Stock","published_at":"2025-03-11T21:18:31.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":959,"price":16.62,"value":15938.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects an aggregate of 959 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the closing price of ANIK common stock on March 7, 2025, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":16276,"source":{"system":"sec-edgar","filing":"0001171843-25-001406","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001406/ownership.xml","form_type":"4"}},{"id":1213501,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Common Stock","published_at":"2025-03-11T21:18:31.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":3296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the second vesting installment of RSUs granted on March 9, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 460 shares purchased on November 14, 2024."}],"balance_after":17235,"source":{"system":"sec-edgar","filing":"0001171843-25-001406","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001406/ownership.xml","form_type":"4"}},{"id":1213500,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2025-03-11T21:17:58.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":5465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024."}],"balance_after":5465,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5465},"source":{"system":"sec-edgar","filing":"0001171843-25-001405","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001405/ownership.xml","form_type":"4"}},{"id":1213499,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2025-03-11T21:17:58.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1604,"price":16.62,"value":26658.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects an aggregate of 1,604 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the closing price of ANIK common stock on March 7, 2025, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":37986,"source":{"system":"sec-edgar","filing":"0001171843-25-001405","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001405/ownership.xml","form_type":"4"}},{"id":1213498,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":60300,"kind":"person","name":"Colleran David","position":1,"cik":"0001646558","reported_name":"Colleran David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel, Corp Sec"}}],"security":"Common Stock","published_at":"2025-03-11T21:17:58.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":5465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the second vesting installment of RSUs granted on March 9, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 800 shares purchased on May 14, 2024 and 330 shares purchased on November 14, 2024."}],"balance_after":39590,"source":{"system":"sec-edgar","filing":"0001171843-25-001405","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001405/ownership.xml","form_type":"4"}},{"id":1213497,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, Director"}}],"security":"Restricted Stock Unit","published_at":"2025-03-11T21:17:13.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":20002,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024."}],"balance_after":20001,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":20002},"source":{"system":"sec-edgar","filing":"0001171843-25-001404","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001404/ownership.xml","form_type":"4"}},{"id":1213496,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, Director"}}],"security":"Common Stock","published_at":"2025-03-11T21:17:13.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":5871,"price":16.62,"value":97576.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects an aggregate of 5,871 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the closing price of ANIK common stock on March 7, 2025, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":166955,"source":{"system":"sec-edgar","filing":"0001171843-25-001404","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001404/ownership.xml","form_type":"4"}},{"id":1213495,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":52260,"kind":"person","name":"Blanchard Cheryl R","position":1,"cik":"0001326530","reported_name":"Blanchard Cheryl R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, Director"}}],"security":"Common Stock","published_at":"2025-03-11T21:17:13.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":20002,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the second vesting installment of RSUs granted on March 9, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 800 shares purchased on May 14, 2024 and 330 shares purchased on November 14, 2024."}],"balance_after":172826,"source":{"system":"sec-edgar","filing":"0001171843-25-001404","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001404/ownership.xml","form_type":"4"}},{"id":1391071,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-10-04T20:06:58.000Z","date":"2024-10-01","kind":"exercise","planned":false,"acquired":false,"shares":2491,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning October 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning October 1, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2491},"source":{"system":"sec-edgar","filing":"0001171843-24-005510","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324005510/ownership.xml","form_type":"4"}},{"id":1391070,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Common Stock","published_at":"2024-10-04T20:06:58.000Z","date":"2024-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":732,"price":24.27,"value":17765.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects an aggregate of 732 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on October 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the closing price of ANIK common stock on October 1, 2024, the trading day on which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":13479,"source":{"system":"sec-edgar","filing":"0001171843-24-005510","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324005510/ownership.xml","form_type":"4"}},{"id":1391069,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Common Stock","published_at":"2024-10-04T20:06:58.000Z","date":"2024-10-01","kind":"exercise","planned":false,"acquired":true,"shares":2491,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the third and final vesting installment of RSUs granted on October 1, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 634 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on May 14, 2024."}],"balance_after":14211,"source":{"system":"sec-edgar","filing":"0001171843-24-005510","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324005510/ownership.xml","form_type":"4"}}],"next_cursor":"2024-10-04T20:06:58.000000Z,1391069"}